Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product


Sistemas Genómicos, a member of the biomedical group ASCIRES, has designed the DGP-GeneSGKit®, the most thorough and sensitive test on the market for detecting aneuploidies, chromosomal segments and unbalanced structural chromosome rearrangements and CNVs based on blastomere and trophectoderm samples for next-generation sequencing (NGS) platforms*.

DGP-GeneSGKit® enables chromosome abnormalities and aneuploidies to be detected with a limit of detection of 20 Mb in human embryos prior to implantation, based on blastomere or  trophectoderm samples using low-coverage whole-genome sequencing.